Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05995886 · ClinicalTrials.gov registry record · NA

Using Facebook to Support Opioid Recovery Among American Indian Women

A NA study of Opioid Use Disorder, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05995886: Recruiting NA study of Opioid Use Disorder, sponsored by Mayo Clinic.

NCT05995886 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05995886, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find out whether a Facebook group will help Native women in recovery from opioid use.

Primary Outcome

The study team will measure the feasibility from the combined reports of recruitment, study retention, level of Facebook intervention uptake/engagement, and treatment satisfaction.

Conditions Studied

Interventions

  • BEHAVIORAL Wiidookaage'win Facebook Group

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-10-16
Est. Completion 2026-10-25
Phase NA
Mayo Clinic

2,844 total trials

What NCT05995886 shows while recruiting

NCT05995886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Wiidookaage'win Facebook Group is the first listed.

NCT05995886 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05995886 about?

NCT05995886 is a clinical study titled "Using Facebook to Support Opioid Recovery Among American Indian Women". The purpose of this study is to find out whether a Facebook group will help Native women in recovery from opioid use.

What is the current status of trial NCT05995886?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-10-16. Estimated completion is 2026-10-25.

What conditions does trial NCT05995886 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT05995886?

The interventions under investigation include: Wiidookaage'win Facebook Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT05995886?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05995886 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05995886's enrollment target sits among peer trials

60 156th of 257 higher than 91 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05995886, the US trial registry maintained by the National Library of Medicine. NCT05995886 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.